RIL
DNTH icon

Rothschild Investment LLC’s Dianthus Therapeutics DNTH Stock Holding History

Rothschild Investment LLC’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.51K Buy
36
+15
+71% +$1.31K ﹤0.01% 2473
2026
Q1 		$1.76K Buy
21
+6
+40% +$347 ﹤0.01% 2616
2025
Q4 		$618 Hold
15
– – ﹤0.01% 2863
2025
Q3 		$590 Hold
15
– – ﹤0.01% 2780
2025
Q2 		$279 Sell
15
-30
-67% -$563 ﹤0.01% 2872
2025
Q1 		$816 Buy
45
+35
+350% +$771 ﹤0.01% 2441
2024
Q4 		$218 Sell
10
-10
-50% -$257 ﹤0.01% 2774
2024
Q3 		$548 Buy
20
+15
+300% +$418 ﹤0.01% 2443
2024
Q2 		$129 Buy
+5
New +$120 ﹤0.01% 2637

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Rothschild Investment LLC's DNTH Position: Q2 2026 in Review

Rothschild Investment LLC increased its Dianthus Therapeutics (DNTH) stake by 71% in Q2 2026, buying an estimated $1.31K and bringing the position to 36 shares worth $3.51K. The position accounts for ﹤0.01% of the portfolio, ranked #2473.

Rothschild Investment LLC first reported a position in DNTH in Q2 2024 and has held it in 9 quarters since. 268 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Rothschild Investment LLC held 36 shares of Dianthus Therapeutics worth $3.51K as of Q2 2026.
  • Rothschild Investment LLC bought 15 Dianthus Therapeutics shares in Q2 2026, an estimated $1.31K.
  • Dianthus Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2473 holding.
  • Rothschild Investment LLC first reported a position in Dianthus Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 268 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.